The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Abstract
Angiogenesis has been associated with the growth, dissemination, and metastasis of solid tumors. The aims of this study were to evaluate the vascularity and the levels of angiogenic factors in patients with acute and chronic leukemias and myelodysplastic syndromes (MDS). The numbers of blood vessels were measured in 145 bone marrow biopsies and the levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), tumor necrosis growth factor-α (TNF-α), tumor growth factor-α (TGF-α), and hepatocyte growth factor (HGF) were determined in 417 plasma samples. Except for chronic lymphocytic leukemia (CLL), vascularity was significantly higher in all leukemias and MDS compared with control bone marrows. The highest number of blood vessels and largest vascular area were found in chronic myeloid leukemia (CML). VEGF, bFGF, and HGF plasma levels were significantly increased in acute myeloid leukemia (AML), CML, CLL, chronic myelomonocytic leukemia (CMML), and MDS. HGF, TNF-α, and bFGF but not VEGF were significantly increased in acute lymphoblastic leukemia (ALL). TNF-α levels were significantly increased in all diseases except for AML and MDS. No significant increase was found in TGF-α in any leukemia or MDS. The highest plasma levels of VEGF were in CML, and the highest plasma levels of bFGF were in CLL. The levels of HGF were highest in CMML. These data suggest that vascularity and angiogenic factors are increased in leukemias and MDS and may play a role in the leukemogenic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Shi, S. R., Key, M. E., & Kalra, K. L. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.6.1709656 · Cited by 2,552
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Basic fibroblast growth factor induces angiogenesis in vitro.
Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., & Orci, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7297 · Cited by 844
Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., Mcculloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., et al. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00379-6 · Cited by 729
Banks, R., Forbes, M., Kinsey, S., Stanley, A., Ingham, E., Walters, C., & Selby, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.158 · Cited by 599
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy, W. T., Richter, L., Frutiger, Y. M., & Grogan, T. M. (1999) · PubMed · Cited by 559
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Pérez‐Atayde, A. R., Sallan, S. E., Tedrow, U. B., Connors, S. L., Allred, E. N., & Folkman, J. (1997) · Europe PMC (PubMed Central) · Cited by 553
Evidence of increased angiogenesis in patients with acute myeloid leukemia
Hussong, J. W., Rodgers, G. M., & Shami, P. J. (2000) · Blood · doi:10.1182/blood.v95.1.309 · Cited by 474
Mignatti, P., Tsuboi, R., Robbins, E., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.671 · Cited by 453
Fiedler, W., Graeven, U., Ergün, S., Verago, S., Kilic, N., Stockschläder, M., & Hossfeld, D. K. (1997) · Blood · doi:10.1182/blood.v89.6.1870 · Cited by 437
Toi, M., Hoshina, S., Takayanagi, T., & Tominaga, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02904.x · Cited by 391
Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., & Merino, M. J. (1995) · Europe PMC (PubMed Central) · Cited by 386
Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van De Water, L., Dvorak, A. M., & Dvorak, H. F. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90004-8 · Cited by 380
Vascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717 · Cited by 319
Self-citationAguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717.423k09_3717_3721 · Cited by 299
Self-citationSieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Ellis, L. M., & Fidler, I. J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00389-9 · Cited by 293
Different angiogenic pathways characterize superficial and invasive bladder cancer.
O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., & Harris, A. L. (1995) · PubMed · Cited by 291
Angiogenesis in myelodysplastic syndromes
Pruneri, G., Bertolini, F., Soligo, D., Carboni, N., Cortelezzi, A., Ferrucci, P. F., Buffa, R., Lambertenghi-Deliliers, G., & Pezzella, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6693515 · Cited by 271
Salven, P., Teerenhovi, L., & Joensuu, H. (1997) · Blood · doi:10.1182/blood.v90.8.3167 · Cited by 249
Leek, R., Landers, R., Fox, S., Ng, F., Harris, A., & Lewis, C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.373 · Cited by 207
Díaz‐Flores, L., Gutiérrez, R., & Varela, H. (1994) · PubMed · Cited by 155
Dosquet, C., Coudert, M., Lepage, É., Cabané, J., & Richard, F. (1997) · PubMed · Cited by 139
Aguayo, Á., O'Brien, S. M., Keating, M. J., et al. (2000) · Blood · doi:10.1182/blood.v96.2.768 · Cited by 106
Self-citationRole of soluble mediators in angiogenesis
Bussolino, F., Albini, A., Camussi, G., Presta, M., Viglietto, G., Ziehe, M., & Persico, G. M. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00390-5 · Cited by 94
Elevated levels of angiogenic cytokines in the plasma of cancer patients
Fuhrmann‐Benzakein, E., Ma, M. N., Rubbia‐Brandt, L., Mentha, G., Ruefenacht, D., Sappino, A., & Pepper, M. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<40::aid-ijc7>3.0.co;2-l · Cited by 87
Gasparini, G. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00376-0 · Cited by 68
Gualandris, A., Urbinati, C., Rusnati, M., Ziche, M., & Presta, M. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610118 · Cited by 62
Clinical trials of antiangiogenic agents
Twardowski, P. W., & Gradishar, W. J. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00015 · Cited by 62
Prognostic value of angiogenesis in gastro-intestinal tumours
Chung, Y. S., Maeda, K., & Sowa, M. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00382-6 · Cited by 50
Cited by
Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1639 · Cited by 1,097
Gupta, D., Treon, S., Shima, Y., Hideshima, T., Podar, K., Tai, Y., Lin, B., Lentzsch, S., Davies, F., Chauhan, D., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402295 · Cited by 553
Spratlin, J. L., Cohen, R. B., Eadens, M., Gore, L., Camidge, D. R., Diab, S., Leong, S., O'Bryant, C., Chow, L. Q. M., Serkova, N. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7537 · Cited by 549
Bone marrow niches in haematological malignancies
Méndez-Ferrer, S., Bonnet, D., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 484
PAGES, G., & POUYSSEGUR, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.032 · Cited by 443
Metadata
- Authors
- Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., Koller, C., Estrov, Z., O'Brien, S., Keating, M., Freireich, E., & Albitar, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-09-15
- Volume
- 96
- Issue
- 6
- Pages
- 2240-2245
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1569016295
- Cited by
- 680
- References
- 40
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.